A major role of PKC θ and NFκB in the regulation of hTERT in human T lymphocytes

FEBS Letters

Volumn 580, Issue 30, 2006, Pages 6819-6824

  Sheng, Wei Yun ^a   Chen, Yi Ru ^a   Wang, Tzu Chien V ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

cMyc; hTERT; NF B; Phytohemagglutinin; T lymphocytes; Telomerase

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOENZYME; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PROTEIN KINASE C THETA; STRESS ACTIVATED PROTEIN KINASE; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR SP1;

ARTICLE; CELL ACTIVITY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; GENE ACTIVITY; GENE CONTROL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; ONCOGENE C MYC; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REPORTER GENE; T LYMPHOCYTE;

CELLS, CULTURED; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; ISOENZYMES; NF-KAPPA B; PROMOTER REGIONS (GENETICS); PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-MYC; T-LYMPHOCYTES; TELOMERASE;

EID: 33845458921     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.11.044     Document Type: Article

References (42)

1. Cong Y.S., Wright W.E., and Shay J.W. Human telomerase and its regulation. Microbiol. Mol. Biol. Rev. 66 (2002) 407-425
2. Blackburn E.H. Telomerases. Annu. Rev. Biochem. 61 (1992) 113-129
3. Shay J.W., and Roninson I.B. Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 23 (2004) 2919-2933
4. Wright W.E., and Shay J.W. Cellular senescence as a tumor-protection mechanism: the essential role of counting. Curr. Opin. Genet. Dev. 11 (2001) 98-103
5. Wright W.E., Piatyszek M.A., Rainey W.E., Byrd W., and Shay J.W. Telomerase activity in human germline and embryonic tissues and cells. Dev. Genet. 18 (1996) 173-179
6. Weng N.P., Levine B.L., June C.H., and Hodes R.J. Regulated expression of telomerase activity in human T lymphocyte development and activation. J. Exp. Med. 183 (1996) 2471-2479
7. Masutomi K., Possemato R., Wong J.M., Currier J.L., Tothova Z., Manola J.B., Ganesan S., Lansdorp P.M., Collins K., and Hahn W.C. The telomerase reverse transcriptase regulates chromatin state and DNA damage responses. Proc. Natl. Acad. Sci. USA 102 (2005) 8222-8227
8. Masutomi K., Yu E.Y., Khurts S., Ben-Porath I., Currier J.L., Metz G.B., Brooks M.W., Kaneko S., Murakami S., DeCaprio J.A., Weinberg R.A., Stewart S.A., and Hahn W.C. Telomerase maintains telomere structure in normal human cells. Cell 114 (2003) 241-253
9. Nakamura T.M., Morin G.B., Chapman K.B., Weinrich S.L., Andrews W.H., Lingner J., Harley C.B., and Cech T.R. Telomerase catalytic subunit homologs from fission yeast and human. Science 277 (1997) 955-959
10. Meyerson M., Counter C.M., Eaton E.N., Ellisen L.W., Steiner P., Caddle S.D., Ziaugra L., Beijersbergen R.L., Davidoff M.J., Liu Q., Bacchetti S., Haber D.A., and Weinberg R.A. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90 (1997) 785-795
11. Harrington L., McPhail T., Mar V., Zhou W., Oulton R., Bass M.B., Arruda I., and Robinson M.O. A mammalian telomerase-associated protein. Science 275 (1997) 973-977
12. Nakayama J., Saito M., Nakamura H., Matsuura A., and Ishikawa F. TLP1: a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell 88 (1997) 875-884
13. Avilion A.A., Piatyszek M.A., Gupta J., Shay J.W., Bacchetti S., and Greider C.W. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res. 56 (1996) 645-650
14. Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C.P., Morin G.B., Harley C.B., Shay J.W., Lichtsteiner S., and Wright W.E. Extension of life-span by introduction of telomerase into normal human cells. Science 279 (1998) 349-352
15. Nakayama J., Tahara H., Tahara E., Saito M., Ito K., Nakamura H., Nakanishi T., Tahara E., Ide T., and Ishikawa F. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat. Genet. 18 (1998) 65-68
16. Vaziri H., and Benchimol S. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr. Biol. 8 (1998) 279-282
17. Counter C.M., Meyerson M., Eaton E.N., Ellisen L.W., Caddle S.D., Haber D.A., and Weinberg R.A. Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase. Oncogene 16 (1998) 1217-1222
18. Horikawa I., Cable P.L., Afshari C., and Barrett J.C. Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. Cancer Res. 59 (1999) 826-830
19. Takakura M., Kyo S., Kanaya T., Hirano H., Takeda J., Yutsudo M., and Inoue M. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res. 59 (1999) 551-557
20. Cong Y.S., Wen J., and Bacchetti S. The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. Hum. Mol. Genet. 8 (1999) 137-142
21. Ducrest A.L., Szutorisz H., Lingner J., and Nabholz M. Regulation of the human telomerase reverse transcriptase gene. Oncogene 21 (2002) 541-552
22. Lin S.Y., and Elledge S.J. Multiple tumor suppressor pathways negatively regulate telomerase. Cell 113 (2003) 881-889
23. Poole J.C., Andrews L.G., and Tollefsbol T.O. Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT). Gene 269 (2001) 1-12
24. Liu K., Schoonmaker M.M., Levine B.L., June C.H., Hodes R.J., and Weng N.P. Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes. Proc. Natl. Acad. Sci. USA 96 (1999) 5147-5152
25. Isakov N., and Altman A. Protein kinase C(theta) in T cell activation. Annu. Rev. Immunol. 20 (2002) 761-794
26. Meller N., Altman A., and Isakov N. New perspectives on PKCtheta, a member of the novel subfamily of protein kinase C. Stem Cells 16 (1998) 178-192
27. Wilkinson S.E., and Nixon J.S. T-cell signal transduction and the role of protein kinase C. Cell Mol. Life Sci. 54 (1998) 1122-1144
28. Bodnar A.G., Kim N.W., Effros R.B., and Chiu C.P. Mechanism of telomerase induction during T cell activation. Exp. Cell Res. 228 (1996) 58-64
29. Igarashi H., and Sakaguchi N. Telomerase activity is induced by the stimulation to antigen receptor in human peripheral lymphocytes. Biochem. Biophys. Res. Commun. 219 (1996) 649-655
30. Sheng W.Y., Chien Y.L., and Wang T.C. The dual role of protein kinase C in the regulation of telomerase activity in human lymphocytes. FEBS Lett. 540 (2003) 91-95
31. Yu C.C., Lo S.C., and Wang T.C. Telomerase is regulated by protein kinase C-zeta in human nasopharyngeal cancer cells. Biochem. J. 355 (2001) 459-464
32. Wooten M.W., Seibenhener M.L., Soh Y., Ewald S.J., White K.R., Lloyd E.D., Olivier A., and Parker P.J. Characterization and differential expression of protein kinase C isoforms in PC12 cells. Differentiation parallels an increase in PKC beta II. FEBS Lett. 298 (1992) 74-78
33. Liu Y., Graham C., Li A., Fisher R.J., and Shaw S. Phosphorylation of the protein kinase C-theta activation loop and hydrophobic motif regulates its kinase activity, but only activation loop phosphorylation is critical to in vivo nuclear-factorκB induction. Biochem. J. 361 (2002) 255-265
34. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L., Coviello G.M., Wright W.E., Weinrich S.L., and Shay J.W. Specific association of human telomerase activity with immortal cells and cancer. Science 266 (1994) 2011-2015
35. Weinmann A.S., and Farnham P.J. Identification of unknown target genes of human transcription factors using chromatin immunoprecipitation. Methods 26 (2002) 37-47
36. Yin L., Hubbard A.K., and Giardina C. NF-κB regulates transcription of the mouse telomerase catalytic subunit. J. Biol. Chem. 275 (2000) 36671-36675
37. Sinha-Datta U., Horikawa I., Michishita E., Datta A., Sigler-Nicot J.C., Brown M., Kazanji M., Barrett J.C., and Nicot C. Transcriptional activation of hTERT through the NF-κB pathway in HTLV-I-transformed cells. Blood 104 (2004) 2523-2531
38. Kimura A., Ohmichi M., Kawagoe J., Kyo S., Mabuchi S., Takahashi T., Ohshima C., Arimoto-Ishida E., Nishio Y., Inoue M., Kurachi H., Tasaka K., and Murata Y. Induction of hTERT expression and phosphorylation by estrogen via Akt cascade in human ovarian cancer cell lines. Oncogene 23 (2004) 4505-4515
39. Greenberg R.A., O'Hagan R.C., Deng H., Xiao Q., Hann S.R., Adams R.R., Lichtsteiner S., Chin L., Morin G.B., and DePinho R.A. Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene 18 (1999) 1219-1226
40. Wang J., Xie L.Y., Allan S., Beach D., and Hannon G.J. Myc activates telomerase. Genes Dev. 12 (1998) 1769-1774
41. Wu K.J., Grandori C., Amacker M., Simon-Vermot N., Polack A., Lingner J., and Dalla-Favera R. Direct activation of TERT transcription by c-MYC. Nat. Genet. 21 (1999) 220-224
42. La Rosa F.A., Pierce J.W., and Sonenshein G.E. Differential regulation of the c-myc oncogene promoter by the NF-κB rel family of transcription factors. Mol. Cell Biol. 14 (1994) 1039-1044